1-4 of 4
Jane Dobbin
Close
Sort by
Journal Articles

Adult T-Cell Leukemia/Lymphoma: Clinical Characteristics and Outcome of Aggressive Subtypes Treated at a Tertiary Cancer Center

Yung Bruno de Melo Gonzaga, MD, Lavinia Bergier, MD MSc, Fabio Leal, MD PhD, Ricardo Bigni, MDMPH, Jane Dobbin, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5610.
https://doi.org/10.1182/blood.V130.Suppl_1.5610.5610
Published: 2017
Journal Articles

Late Responders to Imatinib: Is Timing of Achievement of Complete Cytogenetic and Molecular Responses the Same in Previously Treated as Compared to the Newly Diagnosed CML Patients?

Vanesa Scholl, Roberta Bitencourt, Arthur Moellmann, Rocio Hassan, Moises Rocha, Jane Dobbin, Ilana Zalcberg
Journal: Blood
Blood (2008) 112 (11): 4266.
https://doi.org/10.1182/blood.V112.11.4266.4266
Published: 2008
Journal Articles

AP2 Overexpression: Correlation to a Poor Prognosis in CLL.

Karina Lani Silva, MSc, Deborah Vidal Vasconcellos, MSc, Eric Delfraro de Paula Castro, MSc, Arthur Coelho Moellman, MD, Jane Dobbin, MD, Raquel Ciuvalschi Maia, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4425.
https://doi.org/10.1182/blood.V104.11.4425.4425
Published: 2004
Journal Articles

MDR Proteins Expression in AIDS-Related Non-Hodgkin’s Lymphoma.

Giselle Pinto de Faria, MSc, Luciana de Souza Barreto, MD, Sérgio Romano, MD, Paulo Antônio Faria, MD, Carlos José Ferreira, MD, Jane Dobbin, MD, Claudete Esteves Klumb, MD, PhD, Raquel Ciuvalschi Maia, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 4383.
https://doi.org/10.1182/blood.V104.11.4383.4383
Published: 2004